Professor Richard Scolyer was part of a world-leading duo with Professor Georgina Long that changed the treatment of melanoma using immunotherapy, dramatically improving survival rates. Then in 2023, Scolyer himself was diagnosed with brain cancer — the cancer with one of the lowest survival rates — which has barely improved in more than 20 years. Scolyer has undergone experimental treatment based on the team's previous research on immunotherapy, as well as more conventional treatments. Clinical

And another 1-2 week wait for results on the books 😩 Instead of graduating to every 6 month skin checks, I got more biopsies and an appointment scheduled in 3 months. Schedule your skin checks, friends. Early detection saves lives! 🖤 #melanomaawareness #melanoma #melanomamonday #skincancer | Amber DeLoof